首页>
外国专利>
PRIMER SET FOR AMPLIFYING CYP2C19 GENE, KIT FOR AMPLIFYING CYP2C19 GENE, GENE AMPLIFICATION METHOD, POLYMORPHISM ANALYSIS METHOD, AND DRUG EFFICACY EVALUATION METHOD
PRIMER SET FOR AMPLIFYING CYP2C19 GENE, KIT FOR AMPLIFYING CYP2C19 GENE, GENE AMPLIFICATION METHOD, POLYMORPHISM ANALYSIS METHOD, AND DRUG EFFICACY EVALUATION METHOD
A primer set for CYP2C19*2 includes a forward primer consisting of a base sequence represented by SEQ ID NO:3, and a reverse primer consisting of a base sequence represented by SEQ ID NO:4. A primer set for CYP2C19*3 includes a forward primer consisting of a base sequence represented by SEQ ID NO:5, and a reverse primer consisting of a base sequence represented by SEQ ID NO:6. A primer set for CYP2C19*17 includes a forward primer consisting of a base sequence represented by SEQ ID NO:7, and a reverse primer consisting of a base sequence represented by SEQ ID NO:11. A primer set for CYP2C 19* 17 includes, for example, a forward primer consisting of a base sequence represented by SEQ ID NO:7, and a reverse primer that is an oligonucleotide consisting of a base sequence represented by SEQ ID NO:12.
展开▼
机译：CYP2C19 * 2的引物组包括由SEQ ID NO：3表示的碱基序列组成的正向引物和由SEQ ID NO：4表示的碱基序列组成的反向引物。 CYP2C19 * 3的引物组包括由SEQ ID NO：5表示的碱基序列组成的正向引物和由SEQ ID NO：6表示的碱基序列组成的反向引物。 CYP2C19 * 17的引物组包括由SEQ ID NO：7表示的碱基序列组成的正向引物和由SEQ ID NO：11表示的碱基序列组成的反向引物。 CYP2C 19 * 17的引物组包括，例如，由SEQ ID NO：7表示的碱基序列组成的正向引物，和作为由SEQ ID NO：12表示的碱基序列组成的寡核苷酸的反向引物。
展开▼
